Vaccination

CDC Plans to Conduct Study on Reported Link Between Vaccines and Autism

Iowa Bill Advances Requiring Drug Companies to Waive Immunity from Design Defect Vaccine Injury Lawsuits

DHHS Secretary RFK, Jr. and USDA Secretary Both Say “No” to Bird Flu Vaccine for Chickens

U.S. Government Gives Moderna $176 Million to Develop mRNA Bird Flu Biologic

by Amber Baker

July 14, 2024

On July 2, 2024, the U.S. government awarded a $176 million contract to Moderna, Inc. for the development of an mRNA H5N1 ...

More Parents in U.K. Refuse Childhood Vaccinations

by Rishma Parpia

July 1, 2024

In late 2023, the U.S. Centers for Disease Control and Prevention (CDC) reported that there had been a decline in state required ...

Guillain-Barré Syndrome ‘More Common Than Expected’ in Early RSV Vaccine Trial

by Natasha Hobley

June 25, 2024

Reports of the nervous system disorder Guillain-Barré syndrome (GBS) were “more common than expected” in the older adult population who received the ...

FDA Licenses Merck’s Capvaxive Pneumococcal Vaccine

by TVR Staff

June 23, 2024

On June 17, 2024, the U.S. Food and Drug Administration (FDA) licensed Merck & Company, Inc.'s new pneumococcal conjugate vaccine Capvaxive (formerly ...

Finland Offers Bird Flu Vaccine to Farm Workers

by Rishma Parpia

June 17, 2024

Public health officials in Finland are preparing to offer H5N1 influenza (also known as avian influenza or bird flu) vaccines to people ...

Study Finds Measles Vaccine Far More Likely to Fail in C-Section Babies

by Carolyn Hendler, JD

June 3, 2024

According to a new study published in Nature Microbiology, babies born via Caesarean section (C-section) are likely to fail to respond to ...

Moderna Stops mRNA COVID Biologics Plant Construction in Kenya

by Rishma Parpia

June 3, 2024

Moderna, Inc. announced recently that it has suspended its efforts to build a $200–$500 million mRNA (messenger ribonucleic acid) biologics manufacturing facility ...

WHO Prequalifies Takeda’s Qdenga Dengue Vaccine

by Marco Cáceres and Barbara Loe Fisher

May 28, 2024

On May 10, 2024, the World Health Organization (WHO) granted prequalification status to the Qdenga (TAK-003) dengue vaccine, developed by Takeda Pharmaceutical ...